Antidepressant Recalls Reveal Flaws in Drug Safety Systems
“`html Antidepressant Recalls Expose Gaps in Drug Safety Antidepressant Recalls Expose Gaps in Drug Safety The recent string of antidepressant recalls has sent ripples through the medical community and left patients questioning the reliability of pharmaceutical safeguards. These recalls, though varying in scope and severity, underscore persistent concerns about drug manufacturing standards, regulatory oversight, and…
